As evolving biomarker data and long-term outcomes reshape the role of PARP inhibitor maintenance, oncologists must master increasingly complex testing logistics and clinical evidence to optimize patient outcomes. Join leading ovarian cancer experts in this on-demand session for a focused update on the clinical impact of homologous recombination deficiency (HRD) testing, including BRCA1/2 mutation and markers of genomic instability, in guiding individualized treatment. Explore practical strategies to ensure timely HRD testing, apply biomarker findings in treatment decision-making, and manage PARP inhibitor-associated adverse events to advance patient-centered care. Engage in interactive polling to test your clinical skills in challenging case scenarios and strengthen your ability to bridge the gap between clinical trial endpoints and real-world application.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 415 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedMar 31, 2026
-
Last day to claim creditMar 31, 2027 6 months left
-
PRIME Education, Inc. (PRIME®) Frontline Precision: Applying Clinical Evidence to PARP Inhibitor Maintenance in Advanced Ovarian Cancer
-
PRIME Education, Inc. (PRIME®) Beyond BRCA Mutations: Practical Considerations for Integrating HRD Testing Into Frontline Maintenance Decisions in Advanced Ovarian Cancer
-
PRIME Education, Inc. (PRIME®) Precision Safety: Optimizing Monitoring and Adverse Event Management During Frontline Maintenance With PARP Inhibitors
